SOX4 and neuroblastoma: Our results also showed that the clinical patients’ survival probabilities was positively correlated with SOX4 expression, in which overexpressing SOX4 inhibited NB cell proliferation, elongated the cells’ neurites, and blocked the cell cycle in the G1 phase.